Institutional investors purchased a net $72.0 thousand shares of TROV during the quarter ended December 2015, and now own 36.19% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Bought 13.2 Thousand shares of Trovagene Inc